Fruquintinib (HMPL-013) is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities.
Molecular Weight:
393.39
Purity:
98.84%
CAS Number:
[1194506-26-7]
Formula:
C21H19N3O5
Target:
VEGFR
T2656
* VAT and and shipping costs not included. Errors and price changes excepted